Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort-Reference-Cited by-同舟云学术

Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort

Published:2021-06-18 Issue:10 Volume:5 Page:1689-1703
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Wang Jun¹^ORCID,Conti David V.¹²³,Bogumil David¹,Sheng Xin¹,Noureddin Mazen⁴,Wilkens Lynne R.⁵,Le Marchand Loic⁵,Rosen Hugo R.⁶^ORCID,Haiman Christopher A.¹²³,Setiawan Veronica Wendy¹²³⁶^ORCID

Affiliation:

1. Department of Preventive Medicine Keck School of Medicine of University of Southern California Los Angeles CA USA

2. Center for Genetic Epidemiology Keck School of Medicine University of Southern California Los Angeles CA USA

3. Norris Comprehensive Cancer Center Keck School of Medicine of University of Southern California Los Angeles CA USA

4. Division of Gastroenterology and Hepatology Department of Medicine Cedars‐Sinai Medical Center Los Angeles CA USA

5. Epidemiology Program University of Hawaii Cancer Center Honolulu HI USA

6. Department of Medicine Keck School of Medicine of University of Southern California Los Angeles CA USA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1751

Reference50 articles.

1. From NAFLD to NASH to cirrhosis—new insights into disease mechanisms

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. NAFLD and liver transplantation: Current burden and expected challenges

4. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis

5. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy;World Journal of Gastrointestinal Pathophysiology;2024-08-22

2. Liver fibrosis prediction models in a population of Latina and White women;Journal of Investigative Medicine;2024-07-30

3. Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population;Scientific Reports;2024-04-29

4. Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches;European Journal of Medical Research;2024-03-20

5. Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease;Metabolism and Target Organ Damage;2024-02-26